HEDIMED – Human Exposomic Determinants of Immune Mediated Diseases

Project data

Funding Entity: European Commission

Call: H2020-SC1-2019-Single-Stage-RTD

Coordinator: AMPEREEN KORKEAKOULUSAATIO SR (Finland)

UNISI Principal Investigator: Francesco Dotta

Department: MEDICINE, SURGERY AND NEUROSCIENCE

Start date: 1 January 2020 – End date: 31 December 2024

 

Description

The immune system functions to protect us against invaders. When this protective system malfunctions, it can harm us rather than protect us. Mistaken identification of harmless intruders (e.g. pollen or pet dander) as severe threats is behind allergies and asthma. In autoimmune diseases such as lupus, rheumatoid arthritis and type 1 diabetes, the body’s immune system attacks and destroys healthy cells. The EU-funded HEDIMED project is investigating the role of the exposome in immune-mediated diseases. The exposome is the sum of all of a person’s ‘exposures’ to chemicals and stress in the womb and throughout life. HEDIMED is examining an extensive clinical sample of pregnant women and children, using complete genetic and molecular profiling (omics) and data mining to create open access tools that advance solutions for this growing public health challenge.

Source: Cordis

Project website

This project has received funding from the European Union’s Horizon 2020 programme under GA No 874864